Fish W W, Orre K, Björk I
Eur J Biochem. 1979 Nov 1;101(1):39-44. doi: 10.1111/j.1432-1033.1979.tb04213.x.
The reaction between thrombin and antithrombin results in the formation of an inactive, stable, equimolar complex between the two proteins. However, under most reaction conditions several secondary complex forms, which have lower apparent molecular weights in dodecyl sulfate/polyacrylamide gel electrophoresis, appear concomitantly with or immediately following the production of the primary form of the complex. Purification of nascent, intact complex and treatment of this complex form with thrombin demonstrated that these subsidiary forms of antithrombin-thrombin complex may arise by proteolysis of the nascent complex by excess thrombin. Dissociation of such proteolytically modified complex preparations by hydroxylamine, and examination of the dissociation products by dodecyl sulfate/polyacrylamide gel electrophoresis suggested that degradation occurs primarily in the thrombin part of the complex, and only after prolonged proteolysis in its antithrombin moiety also. Incubation of antithrombin with several autolytically modified thrombin preparations showed that formation of subsidiary complex forms can also occur by an alternative route, i.e. between premodified thrombin forms and the inhibitor. In contrast, complex formation between thrombin and active forms of antithrombin, which have been modified by thrombin before complex formation, is unlikely, since no such active forms of antithrombin could be demonstrated.
凝血酶与抗凝血酶之间的反应导致两种蛋白质之间形成一种无活性、稳定的等摩尔复合物。然而,在大多数反应条件下,几种在十二烷基硫酸钠/聚丙烯酰胺凝胶电泳中表观分子量较低的二级复合物形式,会与主要复合物形式同时出现或在其产生后立即出现。对新生的完整复合物进行纯化,并将该复合物形式用凝血酶处理,结果表明抗凝血酶 - 凝血酶复合物的这些次要形式可能是由于过量凝血酶对新生复合物进行蛋白水解而产生的。用羟胺使这种经蛋白水解修饰的复合物制剂解离,并用十二烷基硫酸钠/聚丙烯酰胺凝胶电泳检查解离产物,结果表明降解主要发生在复合物的凝血酶部分,并且只有在其抗凝血酶部分经过长时间蛋白水解后才会发生。将抗凝血酶与几种经自溶修饰的凝血酶制剂一起孵育表明,次要复合物形式的形成也可以通过另一条途径发生,即在预先修饰的凝血酶形式与抑制剂之间。相比之下,凝血酶与在复合物形成前已被凝血酶修饰的抗凝血酶活性形式之间不太可能形成复合物,因为未发现有这种抗凝血酶活性形式。